Tokyo, June 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000057876) titled 'Balancing Rehabilitation Dose in Acute Stroke Decision-making and Global Evaluation' on June 1.
Study Type:
Observational
Primary Sponsor:
Institute - Other
Condition:
Condition - Stroke
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The aim of this study is to clarify the impact of early rehabilitation dosage on functional independence in patients with acute stroke. Specifically, we will (1) investigate the daily rehabilitation dose administered within the first week of hospitalization, and (2) prospectively examine how rehabilitation dose, intensity, and duration influence functional independence at 90 days post-stroke.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - 1. Stroke patients (cerebral infarction or cerebral hemorrhage) expected to be hospitalized for 7 days or more
2. Age 18 years or more
3. Provision of informed consent
4. Initiation of rehabilitation by day 2 of admission
Key exclusion criteria - 1. Pre-hospitalization mRS 3 or more (unable to walk even with aids)
2. Terminal care patients or those with non-curative intent
3. Patients with anticipated prolonged immobility due to trauma (e.g., multiple unstable fractures, burns, amputations)
4. Inability to communicate in Japanese
5. Explicit refusal to allow use of clinical data for research
Target Size - 200
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 05 Month 01 Day
Anticipated trial start date - 2026 Year 06 Month 01 Day
Last follow-up date - 2027 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066154
Disclaimer: Curated by HT Syndication.
